Related Experiment Videos
[Antihypertensive drug utilization in obese patients]
Peter Bramlage1, Carsten Bramlage, Wilhelm Kirch
1Institut für Klinische Pharmakologie, Technische Universität Dresden, Dresden. peter.bramlage@mailbox.tu-dresden.de
Medizinische Klinik (Munich, Germany : 1983)
|February 3, 2006
Summary
Obese patients with hypertension often receive combination drug therapy, with ACE inhibitors and diuretics most frequently prescribed. However, current treatment strategies may not adequately control blood pressure, necessitating optimized combination regimens.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Context:
- Obesity and arterial hypertension are prevalent, often co-occurring conditions.
- Effective blood pressure management in obese hypertensive patients remains a challenge.
- Limited recent data exist on antihypertensive prescribing patterns in primary care for this population.
Purpose:
- To analyze antihypertensive drug prescription patterns in obese patients with arterial hypertension.
- To identify preferred drug classes, commonly used substances, and dosing strategies.
- To evaluate the adequacy of current pharmacotherapy for blood pressure control in this demographic.
Summary:
- A nationwide observational study analyzed data from over 70,000 hypertensive patients.
- Antihypertensive pharmacotherapy for obese patients showed variation in drug selection but less in dosage.
- Drug combinations, particularly ACE inhibitors and diuretics, were commonly used.
Impact:
- Current antihypertensive drug availability and prescription practices may be insufficient for adequate blood pressure control in obese patients.
- Optimized combination therapy, including reduced doses of certain agents and high doses of RAS inhibitors, could enhance efficacy and reduce side effects.
- Findings highlight the need for improved treatment strategies for managing hypertension in the obese population.